Survey of Mast Cell Mediator Levels from Patients Presenting with Symptoms of Mast Cell Activation von Butterfield, Joseph H.

Volltext

Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome von Valent, Peter, Bonadonna, Patrizia, Hartmann, Karin, Broesby-Olsen, Sigurd, Brockow, Knut, Butterfield, Joseph H., Triggiani, Massimo, Lyons, Jonathan J., Oude Elberink, Joanna N.G., Arock, Michel, Metcalfe, Dean D., Akin, Cem

Volltext

Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes von Valent, Peter, Klion, Amy D., Roufosse, Florence, Simon, Dagmar, Metzgeroth, Georgia, Leiferman, Kristin M., Schwaab, Juliana, Butterfield, Joseph H., Sperr, Wolfgang R., Sotlar, Karl, Vandenberghe, Peter, Hoermann, Gregor, Haferlach, Torsten, Moriggl, Richard, George, Tracy I., Akin, Cem, Bochner, Bruce S., Gotlib, Jason, Reiter, Andreas, Horny, Hans‐Peter, Arock, Michel, Simon, Hans‐Uwe, Gleich, Gerald J.

Volltext

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors von Lim, Ken-Hong, Tefferi, Ayalew, Lasho, Terra L., Finke, Christy, Patnaik, Mrinal, Butterfield, Joseph H., McClure, Rebecca F., Li, Chin-Yang, Pardanani, Animesh

Volltext

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes von Valent, Peter, MD, Klion, Amy D., MD, Horny, Hans-Peter, MD, Roufosse, Florence, MD, PhD, Gotlib, Jason, MD, Weller, Peter F., MD, Hellmann, Andrzej, MD, Metzgeroth, Georgia, MD, Leiferman, Kristin M., MD, Arock, Michel, PharmD, PhD, Butterfield, Joseph H., MD, Sperr, Wolfgang R., MD, Sotlar, Karl, MD, Vandenberghe, Peter, MD, PhD, Haferlach, Torsten, MD, Simon, Hans-Uwe, MD, PhD, Reiter, Andreas, MD, Gleich, Gerald J., MD

Volltext

Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy von Ogbogu, Princess U., MD, Bochner, Bruce S., MD, Butterfield, Joseph H., MD, Gleich, Gerald J., MD, Huss-Marp, Johannes, MD, Kahn, Jean Emmanuel, MD, Leiferman, Kristin M., MD, Nutman, Thomas B., MD, Pfab, Florian, MD, Ring, Johannes, MD, Rothenberg, Marc E., MD, PhD, Roufosse, Florence, MD, Sajous, Marie-Helene, MD, Sheikh, Javed, MD, Simon, Dagmar, MD, Simon, Hans-Uwe, MD, PhD, Stein, Miguel L., MD, Wardlaw, Andrew, MD, Weller, Peter F., MD, Klion, Amy D., MD

Volltext

Metformin: A potential adjunct for treatment of systemic mastocytosis von Butterfield, Joseph H., Bartemes, Kathleen

Volltext

Mast cell activation syndrome: Importance of consensus criteria and call for research von Valent, Peter, Akin, Cem, Bonadonna, Patrizia, Hartmann, Karin, Broesby-Olsen, Sigurd, Brockow, Knut, Butterfield, Joseph H., Reiter, Andreas, Gotlib, Jason, Castells, Mariana, Milner, Joshua D., Carter, Melody C., Komarow, Hirsh, Radia, Deepti, Pardanani, Animesh, Sotlar, Karl, Triggiani, Massimo, Horny, Hans-Peter, Arock, Michel, Schwartz, Lawrence B., Metcalfe, Dean D.

Volltext

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis von Arock, Michel, Wedeh, Ghaith, Hoermann, Gregor, Bibi, Siham, Akin, Cem, Peter, Barbara, Gleixner, Karoline V, Hartmann, Karin, Butterfield, Joseph H, Metcalfe, Dean D, Valent, Peter

Volltext

Non c-Kit Tyrosine Kinase Expression In Mast Cell Leukemia von Butterfield, Joseph H., Dr

Volltext

Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome von Butterfield, Joseph H

Volltext

Successful Long-Term Control of the Syndrome of Episodic Angioedema With Eosinophilia (Gleich Syndrome) With Low-Dose Imatinib Mesylate and Prednisone von Butterfield, Joseph H.

Volltext

Paradoxical Effect of Epinephrine Administration During Anaphylaxis von Jin, Jay, MD, PhD, Butterfield, Joseph H., MD, FAAAAI, Divekar, Rohit, MBBS, PhD

Volltext

Characterization Of Systemic Mastocytosis Patients Based Solely On The Minor Criteria von Ravi, Anupama, Dr, Butterfield, Joseph H., Dr

Volltext

Steroid/ Local Anesthetic Injection Reactions- Which One Is Frequently the Allergic Component? von Patel, Bhavisha, MD, Butterfield, Joseph H., MD, FAAAAI

Volltext

The First US Cohort of Eosinophilic Otitis Media: Clinical Characteristics von Willits, Erin, MD, O'Brien, Erin, MD, Neff, Brian, MD, Butterfield, Joseph H., MD, FAAAAI

Volltext

Response of patients with indolent systemic mastocytosis to tamoxifen citrate von Butterfield, Joseph H., MD, Chen, Dong, PhD

Volltext

Hematologic Malignancies Identified in Patients with Hypereosinophilia and Hypereosinophilic Syndromes von Jin, Jay J., MD, PhD, Butterfield, Joseph H., MD, Weiler, Catherine R., MD, PhD

Volltext

BPR1J373, an Oral Multiple Tyrosine Kinase Inhibitor, Targets c-KIT for the Treatment of c-KIT-Driven Myeloid Leukemia von Chen, Li-Tzong, Chen, Chiung-Tong, Jiaang, Weir-Torn, Chen, Tsai-Yun, Butterfield, Joseph H, Shih, Neng-Yao, Hsu, John Tsu-An, Lin, Hui-You, Lin, Sheng-Fung, Tsai, Hui-Jen

Volltext

Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia von Giannetti, Matthew P., Godwin, Grace, Weller, Emily, Butterfield, Joseph H., Castells, Mariana

Volltext